MegamuttsI cant thank you enough for providing trial feedback...

Megamutts
I cant thank you enough for providing trial feedback .Its extremely helpful to analysis.
It definitely gives us a feel of what management are thinking and where value can be extracted to the benefit of patients and shareholders.
IMU management must be feeling very good about themselves and their science.
I am a holder for many years so its nice to be in this stratosphere of data and share price.
To know a trial end date program is reduced by 12 month is significant.
Well done and thanks
Its anyone's guess as to what the share price will be at the completion of that trial end 2021 when results get announced. All I am thinking is OMG this is great news.

Good luck to all holders.